Krane Funds Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$897K Buy
3,532
+3
+0.1% +$699 0.03% 101
2026
Q1
$851K Buy
3,529
+603
+21% +$140K 0.03% 102
2025
Q4
$606K Sell
2,926
-359
-11% -$71K 0.02% 100
2025
Q3
$633K Buy
3,285
+1,048
+47% +$180K 0.02% 83
2025
Q2
$342K Buy
2,237
+645
+41% +$99.1K 0.01% 96
2025
Q1
$264K Buy
+1,592
New +$249K 0.01% 97
2022
Q3
Sell
-1,560
Closed -$277K 202
2022
Q2
$277K Buy
+1,560
New +$278K 0.01% 184
2022
Q1
Sell
-3,350
Closed -$573K 339
2021
Q4
$573K Buy
3,350
+2,775
+483% +$454K 0.01% 138
2021
Q3
$93K Sell
575
-2,735
-83% -$467K ﹤0.01% 283
2021
Q2
$545K Buy
3,310
+497
+18% +$82.3K 0.02% 180
2021
Q1
$462K Buy
2,813
+988
+54% +$160K 0.02% 174
2020
Q4
$287K Sell
1,825
-760
-29% -$112K 0.01% 239
2020
Q3
$385K Sell
2,585
-25
-1% -$3.7K 0.02% 157
2020
Q2
$367K Buy
+2,610
New +$380K 0.02% 190
2019
Q3
Sell
-184
Closed -$26K 227
2019
Q2
$26K Buy
+184
New +$25.5K ﹤0.01% 121

Other funds holding JNJ

Krane Funds Advisors's JNJ Position: Q2 2026 in Review

Krane Funds Advisors increased its Johnson & Johnson (JNJ) stake by 0.09% in Q2 2026, buying an estimated $699 and bringing the position to 3,532 shares worth $897K. The position accounts for 0.03% of the portfolio, ranked #101.

Krane Funds Advisors first reported a position in JNJ in Q2 2019 and has held it in 15 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Krane Funds Advisors held 3,532 shares of Johnson & Johnson worth $897K as of Q2 2026.
  • Krane Funds Advisors bought 3 Johnson & Johnson shares in Q2 2026, an estimated $699.
  • Johnson & Johnson made up 0.03% of Krane Funds Advisors's portfolio in Q2 2026, its #101 holding.
  • Krane Funds Advisors first reported a position in Johnson & Johnson in Q2 2019 and has held it in 15 quarters since.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Krane Funds Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.